Horowitz: Sen. Johnson calls out the FDA for not approving promising late-stage COVID drug
Novel gene therapies and therapeutics were approved, marketed, distributed, funded, and in some cases mandated by the government based on nothing more than data by the manufacturers themselves. Yet, to this day, not a single “Right to Try” has been
Read More